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Abstract—This paper proposes an adaptive neuro-fuzzy frame-
work to improve drug infusion rate in closed-loop control of anes-
thesia. The proposed controller provides a sub-optimal propofol
administration rate as input to reach the desired bispectral
index, which is the output of the system, in both induction and
maintenance phases. In this controller, a critic agent assesses the
plant output and produces a reinforcement signal to adapt the
controller parameters and minimize the propofol administration
rate. The controller is applied to a conventional pharmacokinetic-
pharmacodynamics model of anesthesia to evaluate its appli-
cability in closed loop-control of anesthesia. To simulate the
designed controller, physiological parameters of 12 patients are
used in the mathematical model. The simulation results show
that the proposed controller can overcome current challenges in
the closed-loop control of anesthesia like inter patient variability,
model uncertainties and surgical disturbances without overdose
or underdose in a time range of 2 to 4 minutes. Analytical
comparison of results shows the strength of the controller in
closed-loop control of anesthesia.
Index Terms—Closed-loop control, Neuro-fuzzy framework,
Intravenous anesthesia, Inter and intra patient variability, Sur-
gical disturbances, Drug infusion, Critic.
I. INTRODUCTION
Biomedical systems are recently the field of interest of
both engineers and clinicians since they are needed to be
mathematically modeled and controlled. These complex and
nonlinear models and controllers improve biologists and clin-
icians decision-making ability since they predict the phys-
iological system’s behavior and make them more sensible.
Drug delivery can be taken to account as the main reason for
these efforts. A standard and desirable drug delivery system is
needed to be automated to prevent additional drug infusion
and their side effects as well as improving their sufficient
in the desired time. There are several studies in different
biologial systems to achive this goal, such as targeted drug
delivery in lung for asthmatic subjects [1]–[3] or in Kidney to
improve the kidney targeted delivery of angiotensin-converting
enzyme [4]. Nowadays, several closed-loop controllers are
developing to use in different drug delivery systems to improve
treatments periods and ways such as glucose regulation of
diabetic patients, blood pressure regulation and treatment of
neurological disorders.
Anesthesia is one of these biomedical systems that need to
be fully understood due to its necessity in most surgical op-
erations. General anesthesia can be obtained by both infusion
drugs (intravenous anesthetics) and vapor drugs (inhalational
anesthetics). These drugs are in different types and conse-
quently have different rules and effects in anesthesia. As seen
in Fig. 1, there are three different targets in general anesthesia.
The first target is analgesia which can be obtained by analgesic
drugs (e.g., remifentanil) administration and indicates that the
patients should be at a certain level of consciousness during
surgery. It makes the patients unawareness about the stages of
surgery and they cannot see the processes, which may have
negative mental effects on them. The second necessary part
of anesthesia is hypnosis. Hypnosis defines that the patients
should not be able to sense any pain in the surgery. This
is one of the important parts of anesthesia since sometimes
patients perceive pain but they cannot show its signs due to
the effects of other drugs. Therefore, the anesthesiologists and
clinicians monitor frequently the patients vital signs like heart
rate, blood pressure, and bispectral index (BIS) and inject
the hypnotic drugs such as propofol. Finally, neuromuscular
blocking (NMB) drugs NMB drugs facilitate the endotracheal
tube insertion.
Besides this category, induction, maintenance and emer-
gency phases are three different steps of intravenous anes-
thesia. This category is based on the different stages of
surgery and defines different tasks for anesthesiologists in
each stage. In the induction phase, which is the first phase
of anesthesia and happens before surgery starts, the main
task of anesthesiologists is decreasing consciousness level of
patients to a standard level. This process should be done
by an optimal drug infusion and minimum undershoot and
overshoot in a standard time frame. As the consciousness
level of the patients stabilizes around the desired level, the
surgery starts and consequently maintenance phase follows.
In this phase, anesthesiologists try to keep the consciousness
level constant at the desired level by frequently drug infusions.
These frequent drug infusions cover the effect of reducing the
impact of previous drugs and eliminate disturbances caused
by different steps of surgery. The latest phase is maintenance
and happens by stopping drug infusion when the surgery is
completely finished.
In the traditional anesthesia, the anesthesiologists defined
the amount, rate and time of injection in each phase based
on their experience and patients vital signs such as heart rate,
blood pressure, lacrimation, sweating and papillary dilatation.
Although the clinicians experience and vital signs contain
valuable information about the patients state, they do not
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Fig. 1. The functional components of general anesthesia.
provide an exact level of the patients consciousness. This
might increase the probability of incidence of awareness
during surgery [5]. Developments in the monitoring of brain
activities have given this opportunity to the anesthesiologists
to have enough online information about different states of
patients during surgery. One of the most common approaches,
in order to exact evaluation of anesthesia, is the bispectral
(BIS) analysis of the electroencephalogram (EEG) signal. This
signal presents electrical activities in the cerebral cortex, which
are related to the consciousness level of the patients. This
signal is quantified from 0 to 100 and called BIS index and the
value 100 denotes full awake or low hypnotic state and as the
analgesia or hypnotic drugs inject to the patient, the BIS index
decreases. The BIS index 50 defines a desirable consciousness
level and a moderate hypnotic state of the patients. This value
is acceptable with a tolerance between 60-40 [6].
As noted, the developed monitors decrease the probability
of clinicians error and consequently increases patients safety in
surgery. However, the accuracy of the conventional anesthesia
method still strongly depends on the expertise of anesthesiol-
ogists to decide about the time and amount of drug infusion
and needs to be developed. In the last two decades, closed-loop
control systems are presented as a useful solution for designing
a sufficient drug delivery system in intravenous anesthesia for
example. This approach has some advantage in comparison to
the traditional and conventional anesthesia such as preventing
too little and much drug infusion, which results in patient
awareness and death respectively, anaesthesiologists workload
reduction, eliminating the possibility of pain-sensing, and
decreasing side effects of drugs. In order to design and imple-
ment a suitable controller that have all the advantages, control
engineers and anesthesiologists are facing several problems.
The first problem is inter and intra patient variability that
implies physiological parameters of patients are significantly
different and change over time and the controller should be
always applicable for a variety of patient. Also, the current
mathematical models contain nonlinear and time delay terms,
which results in some difficulties in designing steps. Another
important problem is the presence of measurement devices
noise and surgical stimulations. These challenges force the
controller engineers to design a sufficient controller which is
adaptive and robust against the uncertainties. Furthermore, the
designed controller should perform two important tasks. The
first one is the determination of the depth of anesthesia. This
happens in the induction phase and defines that the controller
should take best control action (drug infusion rate) to reduce
the consciousness level and the pain-sensing state of the
patients in the desired time frame with minimum undershoot
and overshoot. The second task is control of anesthetic depth,
which points to keep the depth of analgesia (DOA) or depth
of hypnosis (DOH) constant using BIS output (feedback) and
continuous injections.
Several control strategies have been proposed to develop
closed-loop control of anesthesia in recent years. Some studied
used classical proportionalintegralderivative (PID) controller
and have improved its features to be useful in closed-loop
control of anesthesia by applying event base input option
[7]–[9], which rejects the noise, and optimize gain tuning
and scheduling for each phase of anesthesia [10], which
yield less overshoot value and better performance in the
induction and maintenance phases. Next developing control
structure is the model predictive controller (MPC). Same
as PID controller, event base input option improves MPC
performance in noise cancelation in anesthesia by reducing
drug infusion rate changes and it also makes the process more
visible for anesthesiologists [7]–[9]. Also, different advanced
estimation methods, offset-free and state output correction
strategies help the MPC to deal with the inter and intra
patient variability challenge [11]. Both type-1 and type-2 fuzzy
logic controllers are also reported in the literature in closed-
loop control of anesthesia. These controllers are improved
in combination with neural network systems and the genetic
algorithm methods and used in the self-organizing fuzzy logic
controllers to handle the uncertainties and cancel the noises
in anesthesia [12]–[18]. Further, other controller strategies
such as classical adaptive controllers [19], [20], nonlinear H-
infinity controller [21] and positive state observer controller
[22] are employed recently to develop closed-loop control of
anesthesia. A comprehensive reviews can be found in [23].
Although the studies have had some significant improve-
ments in closed-loop control of anesthesia, the noted chal-
lenges and missions are not still completely addressed. In
the current paper, a controller framework is proposed to deal
with the current challenges with a sub-optimal control input.
Adaptive multi-critic based neuro-fuzzy controller (AMCNFC)
is developed in [24] and previously tested successfully in the
biomedical application by [25] to control endpoint movements
of human arms. This control structure is independent of the
Fig. 2. The PK/PD compartmental model of anesthesia (Adapted from [27]).
model parameters and provides the sub-optimal control action
in systems with set point or path tracking target. Here, the
infusion rate of propofol is determined by this controller
to reach the desired depth of hypnosis and stabilize it. It
should be noted that the propofol is used as the hypnotic
drug since it has a lower negative consequence to other
hypnotic drugs [26]. In this paper, it is shown that the proposed
controller has a significant improvement in closed-loop control
of anesthesia, which is the main contribution of this paper, due
to the decreasing quantity of the administered drug, improving
other performance indexes, and preventing overshoot in BIS
response.
The current paper is formed as follows. The con-
ventional mathematical pharmacokinetic-pharmacodynamics
PK/PD model of anesthesia is presented in Section II and the
controller is explained in Section III. The simulation results
are discussed in Section IV while a conclusion is posted in
Section V.
II. MATHEMATICAL MODELING
Mathematical modeling of dynamic systems is the first and
most significant part in controller design. Complete infor-
mation and comprehension about the system behavior make
the designed controller more efficient. This becomes more
complicated for physiological systems due to their complex,
nonlinear and variant dynamics. In this section, as can be seen
in Fig. 2, the conventional PK/PD compartmental model of
anesthesia is presented. This is a single input single output
model and has three main compartments in the PK part and
one effect site compartment in the PD part.
A. Pharmacokinetic Model
When the drugs injected to patients they reach to different
parts of the human body. So it is needed to know in what
proportion of the injected drugs reach the target. The PK
model gives the mathematical model of drug distribution in
the human body. As can be seen in Fig. 1, this model has 3
important compartments. The compartment V1 is defined as
the central compartment and contains important parts such as
blood, brain, and liver. The peripheral compartments V2 and V3
represent other human parts, which receive the infused drugs.
The compartment V2 includes muscles and viscera, which are
well-perfused body tissues and have fast dynamics. On the
contrary, the compartment V3 has a slow dynamic since it is
consist of fat and bones parts, which are poorly perfused body
tissues. This model can be derived by establishing balance
equation for drug concentration xi(mg) in the ith compartment
as:
x˙1 =
I(t)
V1
− k12x1 − k13x1 − k10x1 + k21x2 + k31x3 (1)
x˙2 = k12x1 − k21x2 (2)
x˙3 = k13x1 − k31x3 (3)
where constants kij(min−1) denote the transfer rate of the
drug from compartment i to compartment j and are different
for each patient, the constant k10 shows the rate of the drug
metabolism. In Eq. (1), I(t)(mg/min) is the drug infusion
rate in the central compartment. These equations can be
rewritten in state space format as below [28]:
x˙1x˙2
x˙3
 =
− (k12 + k13 + k10) k21 k31k12 −k21 0
k13 0 −k31
x1x2
x3

+
 1V10
0
 I(t)
(4)
Cp =
[
1 0 0
] x1x2
x3
 (5)
where CP is the amount of the drug in blood plasma and kij
can be obtained as below for the propofol [29]:
k10
k12
k21
k31
k13
 =

1
V1
0 0
0 1V1 0
0 0 1V1
0 1V1 0
0 0 1V1

Cl1Cl2
Cl3
 (6)
where Vi(l) is the volume of compartment i and can be
calculated as:V1V2
V3
 =
 0−0.391
0
 [Age] +
 4.2739.623
238
 (7)
and age is in the year. In Eq. (6), Cli(m/l) can be calculated
as:
Cl1Cl2
Cl3
 =
0.04560
0
0.0264
0
0
−0.0681
0
0
0
−0.024
0
×

Weight
Height
lbm
Age
 +
−2.2710.018
0.836
 (8)
where weight and height are in kg and cm, respectively. In
Eq. (8), lbm is the lean body mass and its formula is different
for males and females. It can be calculated as [30]:
[
lbmm
lbmf
]
=
(
m 0
0 f
)(
1.1 −128
1.07 −148
)[ Weight(
Weight
Height
)2] (9)
In this equation when the patients are male the m and f
parameters are equal to one and zero and when they are female
these values are reversed.
B. Pharmacodynamics Model
The pharmacodynamics model points to express what hap-
pens when the infused drug is in the target compartment. This
model quantifies the effect of the drug concentration on the
target compartment. Effect site compartment and Hill equation
are two parts of this model. The effect site compartment is
first introduced by [31] and its volume size is negligible in
comparison with other compartments [32]. Same as the PK
part, the drug concentration equation of this compartment can
be derived as:
C˙e = x˙e = k1ex1 − ke0xe (10)
where xe denotes drug concentration in the effect site com-
partment and k1e and ke0 are transfer rates of the drug from
the central to the effect site compartment and vice versa. These
parameters are usually assumed to be the same and are equal to
0.456 min−1 for propofol [29]. So, the Eq.10 can be rewritten
as:
C˙e = ke0 (Cp − Ce) (11)
The second and most important part of the PD model is
the Hill equation (sigmoid function). This equation defines
the relation between drug concentration in the effect site
compartment and the BIS index. The nonlinear Hill equation
is given as:
E = E0 − Emax C
γ
e
Cγe + EC
γ
50
(12)
where E0 indicates the baseline value (obtained from the
awake state without propofol), which is typically set to 100;
Emax is the maximum effect achievable by the drug infusion;
EC50 denotes the drug concentration at half maximal effect,
which represents the patients sensitivity to the drug and should
be measured experimentally and γ determines the slope of
Fig. 3. Schematic of the controller structure.
the sigmoid curve (i.e., the receptiveness of the patient to the
drug) [33]. As noted, E in Eq. 12 gives the BIS index in the
range of [0, 100]. The parameters of the Hill equation should
be obtained experimentally and are different for each patient.
Here, a set of 12 patients parameters for propofol infusion
are presented in Table I. This data base is previously used in
literature to simulate the PK/PD model and closed-loop control
of anesthesia. In Table I, the thirteenth patient named nominal
patient and its parameters is the average of the 12 patients.
III. CONTROLLER DESIGN
In order to solve the common challenges of the closed-loop
anesthesia control such as intra and inter patient variability and
the effects of noise, we utilized a kind of adaptive critic-based
neuro-fuzzy controller. This controller is model independent
and can optimize the amount of drug infusion rate. The main
goal of the controller is to minimize the overshoot values
during the induction and disturbance rejection phases. In Fig.
3 a schematic view of this closed-loop control is shown. In the
following parts, we explain different parts of the controller.
A. Neuro-fuzzy controller
A fuzzy system is a method of representing the input-output
relationship of the systems which is inferred by experimental
data. Its structure is based on IF-THEN rules. The inputs
and outputs of the IF-THEN rules are represented by using
continues membership functions [34]. Fuzzy systems can
be used as the controller due to its ability to provide any
desired non-linear mapping between inputs and outputs. For
our specific application, we use a single-input-single-output
TSK-type fuzzy system which is the combination of IF-THEN
rules as follows:
IF (e is Fi) THEN Ci(e) = aie+ bi (13)
where e = (Ed − E)/100 is the error between the measured
and the desired BIS value, i ∈ {1, N} represents the rule
number, Fi is related to its membership function, Ci denotes
the output of rule i in which ai and bi express the constant
coefficients. If the triggering value of each rule is µi(e), then
the net output of the TSK system is
u =
N∑
i=1
µi(e)Ci(e). (14)
For the proposed controller, as shown in Fig. 4, we consider
three triangular membership functions (N = 3) named as
Negative (Ne), Positive (Po) and Zero (Ze) for the input
TABLE I
NUMERICAL VALUES OF THE HILL EQUATIONS PARAMETER [33]
Patient # Age Length (cm) Weight (kg) Gender EC50 E0 Emax γ
1 40 163 54 F 6.33 98.8 94.1 2.24
2 36 163 50 F 6.76 98.6 86 4.29
3 28 164 52 F 8.44 91.2 80.7 4.1
4 50 163 83 F 6.44 95.9 102 2.18
5 28 164 60 M 4.93 94.7 85.3 2.46
6 43 163 59 F 12.1 90.2 147 2.42
7 37 187 75 M 8.02 92 104 2.10
8 38 174 80 F 6.56 95.5 76.4 4.12
9 41 170 70 F 6.15 89.2 63.8 6.89
10 37 167 58 F 13.7 83.1 151 1.65
11 42 179 78 M 4.82 91.8 77.9 1.85
12 34 172 58 F 4.95 96.2 90.8 1.84
13 38 169 65 F 7.42 93.1 96.6 3
Fig. 4. Membership functions for TSK controller.
of the TSK fuzzy controller (e). This results in three rules
for the TSK controller of anesthesia, which is shown in Fig.
5. By using (14), the proposed TSK fuzzy controller can be
represented in the vector form as follows
u = µ¯αX (15)
µ¯ =
[
µ1(e) µ2(e) µ3(e)
]
(16)
α =
a1 b1a2 b2
a3 b3
 (17)
X =
[
e
1
]
(18)
B. The Critic
As shown in Fig. 3, the parameters of the neuro-fuzzy con-
troller (ai and bi) should be updated by using a reinforcement
signal, r. This scaler signal is produced by a critic agent and
is determined by evaluating the output of the system. The idea
is to adapt the tunable parameters of the TSK fuzzy controller
by using this performance criteria. The goal is to force the
controller to minimize the critic signal (r) so that it reaches
zero value [35] and at the same time minimize the control
input (u). Therefore, the cost function is defined as:
Fig. 5. The TSK structure.
J =
1
2
kr2 +
1
2
Ku2 (19)
in which k and K are constant positive values and
r = e (20)
As seen, the cost function is composed of two terms. The
first terms are for minimizing the reinforcement signal which
is equal to the BIS error value in this application, while the
second term is used for minimizing the control input, which
is the drug infusion rate.
C. Emotional Learning
Emotional learning is referred to the method by which the
controller’s parameters are updated by using the reinforcement
signal and the control input signal. We use the steepest descent
algorithm to achieve this goal. This procedure is as follows:
α˙ = −η ∂J
∂α
(21)
where η is the learning rate of the controller. Using partial
differentiation, it will be simplified as follows
α˙ = −η
(
∂J
∂r
∂r
∂E
∂E
∂u
+
∂J
∂u
)
∂u
∂α
(22)
In this application, the system is the minimum phase and
therefore, ∂E∂u ≈ 1, then
α˙ = −η (−kr +Ku) µ¯TXT (23)
which is the dynamic of the TSK fuzzy controllers parameters.
The initial value can be selected randomly.
IV. SIMULATION
The proposed controller is designed based on the nominal
patient information and in this section its ability in closed-
loop control of the PK/PD compartment model is assessed by
simulation results. These simulation results are presented in
both induction and maintenance phases for the 12 patients.
In the designed controller, the TSK parameters are needed
to be selected for the first treatment. These parameters are
selected randomly between −2 and 2. The learning rate is
also selected 2 and the em in Fig. 4 is chosen 0.5. Since the
current infusion pumps have some limitations range and the
infusion rate cannot be a negative value, the infusion rate is
limited in the range of [0, 50] [36]. Also, the sampling rate
is selected 1 second.
A. Induction phase
In this section, the controller is evaluated in the induction
phase. In this phase, the controller should provide an optimal
drug infusion rate to reduce the BIS value to 50, which is the
desired DOH, in an appropriate time range with no overdose.
The settling time is a significant factor in this process and some
parameters are considerable on the settling time definition. As
the learning rate increases the settling time decreases and this
makes more drug infusion. However, too little settling time is
not acceptable by anesthesiologists due to the increase in drug
consumption and their other side effects. Actually, infusion
of a huge drug amount in a short settling time shocks the
human body and might harm other physiological organs of the
patients [37]. However, a long settling time can be obtained
by a lower infusion rate. The definition of this time needs a
trade-off between the side effects and the drug infusion rate.
In the current surgical operations, this time is reported 15
minutes [36] while shorter time is defined in the literature
for simulation studies. In this paper this time is selected to
be in the range of 2 − 4 minutes. The controller is applied
to the PK/PD model of the nominal patient and its potency
in control of the BIS value is shown in Fig. 6 while Fig. 7
represents the control action. Fig. 6 shows the desired DOH is
obtained in the defined settling time. It also indicates that the
provided sub-optimal control action prevents any overshoot or
undershoot close to the desired BIS value.
The next test is evaluating the proposed controller in the
presence of inter and intra patient variability challenge. This
implies that the controller should be applied to the PK/PD
model of other patients in Table I. It should be noted that the
patient 9 is defined as the most sensitive and challengeable
patient in [36]. Fig. 8 and Fig. 9 indicate the controller can
deal with the challenge successfully. As shown, for different
patients the designed controller provides different control
action while its performance and the system output does not
change significantly due to lack of overshoot and long settling
Fig. 6. BIS output for the nominal patient in the induction phase.
Fig. 7. Drug Infusion for the nominal patient in the induction phase.
time in the responses. To evaluate the controller performance
against the measurement devices noise, a band-limited white
noise is applied to the system output (BIS values). Since the
controller is independence from the model and optimizes the
control action online, as can be seen in Fig. 10 and Fig. 11,
the controller is robust against the noises.
B. Maintenance phase
As noted, the second mission of the controller is keeping the
BIS value constant in the maintenance phase. In this section,
this feature of the controller is evaluated by applying standard
surgical stimulations and noises to the system output. Here,
as shown in Fig. 12, a standard surgical stimulation profile
Fig. 8. BIS output for all patients in the induction phase (patient 9: dash
line).
TABLE II
PERFORMANCE INDEXES VALUES OF THE CONTROLLERS
Index PID controller [10] Event-based PID controller [8] AMCNFC
IAE 3499 (for Worst-case IAE) 3932 (for Nominal patient) 2918.9 (for Worst-case)2215.9 (for Nominal patient)
MDPE [%] 0.46 1.16 0.61 0.51 0.3 0.09
MDAPE [%] 1.21 1.33 1.44 0.71 0.3 0.09
WOBBLE [%] 1.21 0.56 2.34 0.95 0.1 0.05
TV 60.97 2.53 4.3 0.74 13.8 3.88
Q [mg] 317.71 51.84 308.12 50.25 120.67 24.38
Fig. 9. Drug Infusion for all patients in the induction phase (patient 9: dash
line).
Fig. 10. Noise effect on BIS output for all patients in the induction phase.
Fig. 11. Drug Infusion for all patients in the induction phase in the presence
of noise.
Fig. 12. A standard surgical stimulations profile.
Fig. 13. BIS output for all patients in the maintenance phase (patient 9:
orange dash line, nominal patient: blue dash line).
is employed to model the disturbances in the simulation [38].
This profile contains some important steps in general surgeries,
which effect on the BIS value. In Fig. 12, A shows the arousal
due to laryngoscopy/intubation; B represents surgical incision
followed by a period of no surgical stimulation (e.g., waiting
for a pathology result); C represents an abrupt stimulus after
a period of low-level stimulation; D expresses the onset of a
continuous normal surgical stimulation; E, F , and G simulate
short-lasting, larger stimulation within the surgical period; and
H denotes the withdrawal of stimulation during the closing
period in [38]. Fig. 13 and Fig. 14 shows that these surgical
stimulations are applied to the model of all patients including
the nominal patient without the noise while Fig. 15 and Fig. 16
show the results in the presence of the noise. The results prove
that the controller is able to reject the surgical disturbances and
conceal the noises by sub-optimal control action.
Fig. 14. Drug Infusion for all patients in the maintenance phase.
Fig. 15. Noise effect on BIS output for all patients in the maintenance phase.
To show the strength of the proposed controller, the results
are compared with some MPC and PID controllers which have
been recently used in closed-loop control of anesthesia. The
proposed controller in the current paper can provide a fast
response with no overshoot and undershoot in BIS response
while the MPC, robust and non-overshooting controllers re-
cently presented by [36], [39], [40] have longer settling time
and cause overshoot in BIS response. Furthermore, here,
the performance indexes given in [38] are used, to have
an analytical comparison and deeper evaluation of the pre-
sented controller. These indexes are integrated absolute error
(IAE), performance error (PE), median performance error
Fig. 16. Drug Infusion for all patients in the maintenance phase in the
presence of noise.
(MDPE), median absolute performance error (MDAPE),
total variation (TV ), Q (quantity of administered drug), and
WOBBLE (an index of response variations over time) and can
be calculated as
IAE =
∫ ∞
0
∣∣BIS −BIS(t))∣∣ dt (24)
TV =
∞∑
k=0
|uk − uk−1| (25)
PEij =
BISj −BIS
BIS
× 100 j = 1, ..., Nj (26)
MDPEi = Median{PEij j = 1, ..., Nj} (27)
MDAPEi = Median{|PEij | j = 1, ..., Nj} (28)
WOBBLEi = Median{|PEij−MDAPEi| j = 1, ..., Nj}
(29)
where BIS is the desired BIS value, BIS(t) is the measured
BIS, uk is the current drug infusion rate, u(k−1) is the previous
drug infusion rate, i denotes the patient number, j is the sample
number, and Nj defines the number of PE values of each
patient. Table II shows the mean values and standard devia-
tions of these indexes reported in [10] and [8] and obtained
results in this paper. As can be seen, the AMCNFC can
provide lower MDPE, which means it prevents overdosing.
Since there is no overshoot, the value of MDAPE is same as
MDPE for the proposed controller and has a lower value than
two other controllers. This shows that AMCNFC is a tighter
controller and can reduce the periods of excessive anesthesia
or reduce risk of awareness [8]. Lower MDAPE results in
lower WOBBLE, which is more preferable from the clinical
point of view. Also, as can be seen, the AMCNFC has lower
IAE and Q values due to the absence of overshoot in BIS
response and ability of providing a sub-optimal control action.
As can be seen in Table II, the total variation of the proposed
controller is acceptable, while the event based PID controller
presented in [8] has slightly smaller TV due to establishing
event based concept in the PID controller.
V. CONCLUSION
In this paper, the applicability of an adaptive neuro-fuzzy
strategy in the closed-loop control of anesthesia has been
evaluated numerically. The designed controller is evaluated in
both induction and maintenance phases and proved its ability
to provide an acceptable drug infusion rate for reaching the
desired DOH. The results show that there is no overshoot
and undershoot around the desired DOH and it is reached
by a sub-optimal drug infusion in the desired time range. To
evaluate the controllers ability in dealing with inter and intra
patient variability challenge, the proposed controller is applied
to the PK/PD model of the 12 patients. The results indicate
that the controller is adaptive and robust against this challenge
and the measurement devices noises due to its independence
from model parameters. The simulation results also show
that the controller is able to reject the conventional surgical
disturbances in the maintenance phase and can improve closed-
control of anesthesia.
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